Examination of Neuromotor Development of Cases Diagnosed with Scaphocephaly
1 other identifier
observational
21
1 country
1
Brief Summary
It's an observational study. Purpose of the study: To evaluate the neuromotor development of scaphocephaly cases. 21 infants diagnosed with scaphocephaly aged 2-17 months were included.
- Is there any delay in the neuromotor development of scaphocephaly cases?
- If delay is observed, in which area is it most common? Denver-II Developmental Screening Test and Alberta Motor Infant Scale were applied to the participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
February 28, 2024
CompletedFirst Posted
Study publicly available on registry
March 5, 2024
CompletedSeptember 19, 2024
September 1, 2024
5 years
February 28, 2024
September 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Denver-II Developmental Screening Test
It's a screening test used in children aged 0-6 years. The test is done in a short time like 5-20 min. The person who will administer the Denver-II test; must be trained and certified. Standardized test materials are used. The test consists of 4 sections and 134 items. There are personal-social, language, fine motor and gross motor sections. The test result is classified as Normal-Abnormal-Suspicious.
baseline
Alberta Infant Motor Scale
It's used to observe gross motor functions and evaluate the effectiveness of the intervention in typically developing infants between 0-18 months. The duration of the test is 10 min and consists of 58 items. The child's spontaneous movements are evaluated in 4 different positions without touching the child. 1 point is taken for each item that can be done. A table containing the mean and standard deviation for each month is used. The test result is classified as Normal-Abnormal-Suspicious.
baseline
Study Arms (1)
Examination of neuromotor development of cases diagnosed with scaphocephaly
21 cases with scaphocephaly were included. Neuromotor development was evaluated with the Denver-II Developmental Screening Test and Alberta Infant Motor Scale.
Interventions
21 cases with scaphocephaly diagnoses were included. Neuromotor development was evaluated with the Denver-II Developmental Screening Test and Alberta Infant Motor Scale.
Eligibility Criteria
21 cases diagnosed with scaphocephaly aged 2-17 monts were included.
You may qualify if:
- Having been diagnosed with scaphocephaly
- Being between 0-18 months
You may not qualify if:
- Be over 18 months
- Having a diagnosed disease other than scaphocephaly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Acıbadem Altunizade Hospital
Istanbul, Uskudar, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pediatric Physiotherapist
Study Record Dates
First Submitted
February 28, 2024
First Posted
March 5, 2024
Study Start
January 1, 2019
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be made available to other researchers.